Aegerion Pharmaceuticals to Announce Third Quarter 2012 Financial Results on Wednesday, November 7

CONTACT: Aegerion Pharmaceuticals, Inc. Michael Lawless, VP, IR 857-242-5028

Aegerion Pharmaceuticals, Inc.